These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9928579)

  • 41. Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group.
    van Tienhoven G; Voogd AC; Peterse JL; Nielsen M; Andersen KW; Mignolet F; Sylvester R; Fentiman IS; van der Schueren E; van Zijl K; Blichert-Toft M; Bartelink H; van Dongen JA
    Eur J Cancer; 1999 Jan; 35(1):32-8. PubMed ID: 10211085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise.
    Møller S; Jensen MB; Ejlertsen B; Bjerre KD; Larsen M; Hansen HB; Christiansen P; Mouridsen HT;
    Acta Oncol; 2008; 47(4):506-24. PubMed ID: 18465317
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and Treatment of Cancer.
    Wagenaar HC; Trimbos JB; Teodorovic I; Therasse P; Vergote I
    Gynecol Obstet Invest; 2004; 57(2):66-71. PubMed ID: 14671413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Massage therapy reduces physical discomfort and improves mood disturbances in women with breast cancer.
    Listing M; Reisshauer A; Krohn M; Voigt B; Tjahono G; Becker J; Klapp BF; Rauchfuss M
    Psychooncology; 2009 Dec; 18(12):1290-9. PubMed ID: 19189275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    Julien JP; Bijker N; Fentiman IS; Peterse JL; Delledonne V; Rouanet P; Avril A; Sylvester R; Mignolet F; Bartelink H; Van Dongen JA
    Lancet; 2000 Feb; 355(9203):528-33. PubMed ID: 10683002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
    Vrieling C; Collette L; Bartelink E; Borger JH; Brenninkmeyer SJ; Horiot JC; Pierart M; Poortmans PM; Struikmans H; Van der Schueren E; Van Dongen JA; Van Limbergen E; Bartelink H
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):667-76. PubMed ID: 10524421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A survey on staging and treatment in uterine cervical carcinoma in the Radiotherapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
    Coucke PA; Maingon P; Ciernik IF; Phuoc Do H
    Radiother Oncol; 2000 Mar; 54(3):221-8. PubMed ID: 10738080
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Milestone clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP).
    Rastogi P; Wickerham DL; Geyer CE; Mamounas EP; Julian TB; Wolmark N
    Chin Clin Oncol; 2017 Feb; 6(1):7. PubMed ID: 28285537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    Depardon E; Kanoun S; Humbert O; Bertaut A; Riedinger JM; Tal I; Vrigneaud JM; Lasserre M; Toubeau M; Berriolo-Riedinger A; Dygai-Cochet I; Fumoleau P; Brunotte F; Cochet A
    PLoS One; 2018; 13(7):e0199529. PubMed ID: 30011328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective comparison of breast pain in patients participating in a randomized trial of breast-conserving surgery and tamoxifen with or without radiotherapy.
    Rayan G; Dawson LA; Bezjak A; Lau A; Fyles AW; Yi QL; Merante P; Vallis KA
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):154-61. PubMed ID: 12504048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer.
    Eur J Cancer; 1997 Aug; 33(9):1361-3. PubMed ID: 9337674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): 5 years of European collaboration in new drug development for breast cancer.
    Awada A; Van Vreckem A; Paridaens R; Bruning PF; Klijn J; Tomiak E; Vinholes J; Roy JA; Kusenda Z; Hoctin Boes G; Van Glabbeke M; Piccart MJ
    Eur J Cancer; 1997 Jul; 33(8):1173-6. PubMed ID: 9301438
    [No Abstract]   [Full Text] [Related]  

  • 54. Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma.
    Eggermont AM
    Eur J Cancer; 1998 Jul; 34 Suppl 3():S22-6. PubMed ID: 9849405
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The programme of quality assurance of the EORTC radiotherapy group. A historical overview.
    Horiot JC; van der Schueren E; Johansson KA; Bernier J; Bartelink H
    Radiother Oncol; 1993 Nov; 29(2):81-4. PubMed ID: 8310157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.
    Pritchard KI
    Cancer; 1994 Aug; 74(3 Suppl):1150-5. PubMed ID: 8039151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of locoregional treatment on the early-stage breast cancer patients: a retrospective analysis.
    van der Hage JA; Putter H; Bonnema J; Bartelink H; Therasse P; van de Velde CJ;
    Eur J Cancer; 2003 Oct; 39(15):2192-9. PubMed ID: 14522378
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.
    Pawinski A; Sylvester R; Kurth KH; Bouffioux C; van der Meijden A; Parmar MK; Bijnens L
    J Urol; 1996 Dec; 156(6):1934-40, discussion 1940-1. PubMed ID: 8911360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cooperative research into the treatment of breast cancer].
    Demidov VP; Ostrovtsev LD; Kovalev BN; Pak DD; Stranadko EF
    Vopr Onkol; 1987; 33(2):33-7. PubMed ID: 2950659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.